El factor de activación de las plaquetas.

Same author

Platelet P2 receptors: from curiosity to clinical targets.

Journal of the autonomic nervous system·2000

Same author

(-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0923), a selective D2 dopamine receptor agonist demonstrates the presence of D2 dopamine receptors in the mouse vas deferens but not in the rat vas deferens.

The Journal of pharmacology and experimental therapeutics·1993

Same author

Pharmacological receptors on blood platelets.

Pharmacological reviews·1991

Same author

Determinants of the atherogenic flux of low-density lipoprotein into arteries.

Arzneimittel-Forschung·1990

Same author

Subtypes of P2-purinoceptors. Studies using analogues of ATP.

Annals of the New York Academy of Sciences·1990

Same author

Evaluation of the binding to fixed platelets of agonists and antagonists of ADP-induced aggregation.

Thrombosis and haemostasis·1989

Videos de Experimentos Relacionados

El factor de activación de las plaquetas.

Videos de Conceptos Relacionados

Platelet P2 receptors: from curiosity to clinical targets.

(-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0923), a selective D2 dopamine receptor agonist demonstrates the presence of D2 dopamine receptors in the mouse vas deferens but not in the rat vas deferens.

Pharmacological receptors on blood platelets.

Determinants of the atherogenic flux of low-density lipoprotein into arteries.

Subtypes of P2-purinoceptors. Studies using analogues of ATP.

Evaluation of the binding to fixed platelets of agonists and antagonists of ADP-induced aggregation.

Videos de Experimentos Relacionados

El factor de activación de las plaquetas.

Videos de Conceptos Relacionados

Platelet P2 receptors: from curiosity to clinical targets.

(-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0923), a selective D2 dopamine receptor agonist demonstrates the presence of D2 dopamine receptors in the mouse vas deferens but not in the rat vas deferens.

Pharmacological receptors on blood platelets.

Determinants of the atherogenic flux of low-density lipoprotein into arteries.

Subtypes of P2-purinoceptors. Studies using analogues of ATP.

Evaluation of the binding to fixed platelets of agonists and antagonists of ADP-induced aggregation.

Videos de Experimentos Relacionados

El factor de activación de las plaquetas.

Videos de Conceptos Relacionados

Artículos Relacionados

Platelet P2 receptors: from curiosity to clinical targets.

(-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0923), a selective D2 dopamine receptor agonist demonstrates the presence of D2 dopamine receptors in the mouse vas deferens but not in the rat vas deferens.

Pharmacological receptors on blood platelets.

Determinants of the atherogenic flux of low-density lipoprotein into arteries.

Subtypes of P2-purinoceptors. Studies using analogues of ATP.

Evaluation of the binding to fixed platelets of agonists and antagonists of ADP-induced aggregation.

Videos de Experimentos Relacionados

El factor de activación de las plaquetas.

Videos de Conceptos Relacionados

Artículos Relacionados

Platelet P2 receptors: from curiosity to clinical targets.

(-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0923), a selective D2 dopamine receptor agonist demonstrates the presence of D2 dopamine receptors in the mouse vas deferens but not in the rat vas deferens.

Pharmacological receptors on blood platelets.

Determinants of the atherogenic flux of low-density lipoprotein into arteries.

Subtypes of P2-purinoceptors. Studies using analogues of ATP.

Evaluation of the binding to fixed platelets of agonists and antagonists of ADP-induced aggregation.